These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4309069)

  • 21. Clostridium perfringens toxins (type A, B, C, D, E).
    McDonel JL
    Pharmacol Ther; 1980; 10(3):617-55. PubMed ID: 6255496
    [No Abstract]   [Full Text] [Related]  

  • 22. Avirulent Clostridium perfringens strains obtained by euflavine treatment.
    Paquette G; Fredette V
    J Bacteriol; 1967 Nov; 94(5):1437-42. PubMed ID: 4293665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular permeability changes in inflammation. II. The effect of lecithinase antagonists in ultraviolet injury in the guinea-pig.
    Logan G; Wilhelm DL
    Br J Exp Pathol; 1966 Aug; 47(4):324-30. PubMed ID: 4958347
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of the C-lecithinase of Cl. perfringens type A on the blood and bone marrow of guinea pigs].
    Anosov IIa; Ispolotovskaia MV; Larina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Aug; 47(8):117-22. PubMed ID: 4322590
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunization of sheep against experimental Clostridium perfringens type A enteritis.
    Niilo L; Hauschild AH; Dorward WJ
    Can J Microbiol; 1971 Mar; 17(3):391-5. PubMed ID: 4323916
    [No Abstract]   [Full Text] [Related]  

  • 26. Enterotoxin production by lecithinase-positive and lecithinase-negative Clostridium perfringens isolated from food poisoning outbreaks and other sources.
    Skjelkvåle R; Stringer MF; Smart JL
    J Appl Bacteriol; 1979 Oct; 47(2):329-39. PubMed ID: 232099
    [No Abstract]   [Full Text] [Related]  

  • 27. Lecithinase activity of mutant and wild strains of Clostridium perfringens.
    Schulze JA; Nakamura M
    Appl Microbiol; 1968 Oct; 16(10):1619-20. PubMed ID: 4300899
    [No Abstract]   [Full Text] [Related]  

  • 28. Properties of Clostridium perfringens (welchii) type-A alpha-toxin (phospholipase C) purified by electrofocusing.
    Smyth CJ; Arbuthnott JP
    J Med Microbiol; 1974 Feb; 7(1):41-66. PubMed ID: 4369079
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative study of the in vitro cytotoxic activity, lecithinase activity and lethality in mice of Clostridium welchii alpha-toxin].
    Collotti C; Piccoli F; Vella L; Zampieri A
    Ann Ist Super Sanita; 1968; 4(5):633-40. PubMed ID: 4308896
    [No Abstract]   [Full Text] [Related]  

  • 30. [Isolation and properties of lecithinase from Clostridium perfringens].
    Shemanova GF; Vlasova EV; Tsvetkov VS; Logunov AI; Levin FB
    Biokhimiia; 1968; 33(1):130-6. PubMed ID: 4299200
    [No Abstract]   [Full Text] [Related]  

  • 31. The lecithinase (alpha toxin) activity of strains of Clostridium perfringens.
    Nakamura M; Cross WR
    Proc Soc Exp Biol Med; 1968 Mar; 127(3):719-22. PubMed ID: 4297194
    [No Abstract]   [Full Text] [Related]  

  • 32. [alpha-toxin (phospholipase C) of Clostridium perfringens (author's transl)].
    Ohsaka A
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():121-44. PubMed ID: 194279
    [No Abstract]   [Full Text] [Related]  

  • 33. Virulence factors of Clostridium perfringens.
    Smith LD
    Rev Infect Dis; 1979; 1(2):254-62. PubMed ID: 232935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Action of a lecithinase omega of Clostridium Welchii on the hepatic enzyme oxidizing octanoate].
    LEVY M; LEGRAND J
    Bull Soc Chim Biol (Paris); 1954; 36(6-7):789-98. PubMed ID: 13199556
    [No Abstract]   [Full Text] [Related]  

  • 35. Structural and compositional changes in the red cell membrane during Clostridium welchii infection.
    Simpkins H; Kahlenberg A; Rosenberg A; Tay S; Panko E
    Br J Haematol; 1971 Aug; 21(2):173-82. PubMed ID: 4327045
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro lecithinase activity and sensitivity to 22 antimicrobial agents of Clostridium perfringens isolated from necrotic enteritis of broiler chickens.
    Kondo F
    Res Vet Sci; 1988 Nov; 45(3):337-40. PubMed ID: 2905509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The occurrence of Clostridium welchii type C in Papua New Guinea.
    Lawrence G; Walker PD; Garap J; Avusi M
    P N G Med J; 1979 Mar; 22(1):69-73. PubMed ID: 233178
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dynamics of the morphological changes to the intramuscular administration of Cl. oedematiens toxin].
    Egoshin IS; Peregudov TA; Pol'nikov DG
    Veterinariia; 1975 Nov; (11):35-7. PubMed ID: 1216465
    [No Abstract]   [Full Text] [Related]  

  • 39. Transient increase in capillary permeability induced by Clostridium perfringens type A enterotoxin.
    Stark RL; Duncan CL
    Infect Immun; 1972 Jan; 5(1):147-50. PubMed ID: 4348076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Aggregating action of phospholipase C of Clostridium welchii on human platelets].
    Chap H; Lloveras J; Douste-Blazy L
    C R Acad Hebd Seances Acad Sci D; 1971 Oct; 273(16):1452-5. PubMed ID: 4332362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.